Progress: Procedure completed
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | CONT | VAUGHAN Derek ( S&D) | DEUTSCH Tamás ( PPE), VISTISEN Anders ( ECR), ALI Nedzhmi ( ALDE), JÁVOR Benedek ( Verts/ALE), VALLI Marco ( EFDD), KAPPEL Barbara ( ENF) |
Committee Opinion | ENVI | LA VIA Giovanni ( PPE) | Julie GIRLING ( ECR), Benedek JÁVOR ( Verts/ALE), Karin KADENBACH ( S&D), Jasenko SELIMOVIC ( ALDE) |
Lead committee dossier:
Subjects
Events
PURPOSE: to grant discharge to the European Chemicals Agency (ECHA) for the financial year 2014.
NON LEGISLATIVE ACT: Decision (EU) 2016/1513 of the European Parliament on discharge in respect of the implementation of the budget of the European Chemicals Agency for the financial year 2014.
CONTENT: with the present decision, the European Parliament grants discharge to the Executive Director of the European Chemicals Agency discharge in respect of the implementation of the Agency's budget for the financial year 2014.
This decision is in line with the European Parliament's resolution adopted on 28 April 2016 and comprises a series of observations that form an integral part of the discharge decision (please refer to the summary of the opinion of 28 April 2016).
Amongst Parliament’s main observations in the resolution accompanying the discharge decision, the latter noted that the expenditure for procedures associated with the new implementation of the biocidal products Regulation was to be covered by application fees for the registration of biocidal products. However, the fees collected in 2014 covered only 17 % of this expenditure and the remaining part was financed by contributions to the Agency’s budget from the Union and the European Free Trade Association (EFTA) countries. It therefore called on the Agency to take account of this difference in the future.
The European Parliament decided to grant discharge to the Executive Director of the European Chemicals Agency (ECHA) in respect of the implementation of the budget for the financial year 2014. The vote on the discharge decision covers the closure of the accounts (in accordance with Annex V, Article 5(1)(a) to its Rules of Procedure).
Noting that the Court of Auditors issued a statement of assurance as to the reliability of the accounts and the legality and regularity of the underlying transactions for the financial year 2014, Parliament adopted by 508 votes to 121, with 7 abstentions, a resolution containing a number of recommendations that needed to be taken into account when the discharge is granted, in addition to the general recommendations that appear in the draft resolution on performance, financial management and control of EU agencies :
Agency’s financial statements : Parliament noted that the final budget of the European Chemicals Agency for the financial year 2014 was EUR 114 112 193 representing an increase of 6.37 % compared to 2013. Budget and financial management : Parliament noted that budget monitoring efforts during the financial year 2014 resulted in a budget implementation rate of 97.08 % and that the payment appropriations execution rate was 87.46 %. Fees and management of biocide products : Parliament recalled that, as of 2012, the Agency was given the task of managing and carrying out technical, scientific and administrative aspects of Regulation (EU) No 528/2012 of the European Parliament and of the Council ( Biocidal Products Regulation - BPR), as well as similar tasks related to the export and import of hazardous chemicals. It also recalled that, with respect to the BPR Regulation, the expenditure for procedures associated with the new implementation of the BPR Regulation was to be covered by application fees for the registration of biocidal products. It acknowledged that the fees collected in 2014 covered only 17 % of this expenditure and the remaining part was financed by contributions to the Agency’s budget from the Union and the European Free Trade Association (EFTA) countries. It took note of the Agency's comment about the Commission's incorrect assumption of the Agency's largely self-financing nature regarding the BPR related costs. It noted the difficulties of the Agency, in the absence of a financial reserve, to obtain additional subsidies in those years where the financial revenue from biocide fees will be lower than estimated and took note of the Agency's concern that if this situation continues and is not compensated by a higher subsidy, it will be extremely difficult for it to continue to deliver on all its non-fee related obligations.
It also stressed that the Agency received a Union contribution for the PIC Regulation totalling EUR 1.3 million in 2014 , a contribution that allowed it to finalise the preparatory activities and ensure the successful entry into application of the PIC Regulation on 1 March 2014.
Parliament made a series of observations regarding commitments and carryovers, payments, contract award, recruitment and internal audit and control procedures.
As far as the issue of preventing conflicts of interest is concerned, Parliament noted the Agency has four scientific committees set up by its founding regulation which issue formal opinions and recommendations. Those committees consist of experts, almost all of whom are public officials, nominated or appointed by the Member States, while the stakeholders are only allowed to participate as observers. It acknowledged that the prevention of conflicts of interest for those committee members is strictly managed by the Agency’s procedure on the prevention and management of potential conflicts of interest, including annual declarations of interests and oral declarations at the start of each meeting.
Lastly, Parliament noted from the Agency that it continues to work on increasing the efficiency and effectiveness of its operations.
The Committee on Budgetary Control adopted the report by Derek VAUGHAN (S&D, UK) on discharge in respect of the implementation of the budget of the European Chemicals Agency for the financial year 2014.
The parliamentary committee calls on the European Parliament to grant the Executive Director of the Agency discharge in respect of the implementation of the agency’s budget for the financial year 2014.
Noting that the Court of Auditors issued a statement of assurance as to the reliability of the accounts and the legality and regularity of the underlying transactions for the financial year 2014, Members call on Parliament to approve the closure of the Agency’s accounts. They made, however, a number of recommendations that needed to be taken into account when the discharge is granted, in addition to the general recommendations that appear in the draft resolution on performance, financial management and control of EU agencies :
· Agency’s financial statements: Members noted that the final budget of the European Chemicals Agency for the financial year 2014 was EUR 114 112 193 representing an increase of 6.37 % compared to 2013.
· Budget and financial management: Members noted that budget monitoring efforts during the financial year 2014 resulted in a budget implementation rate of 97.08 % and that the payment appropriations execution rate was 87.46 %.
· Fees and management of biocide products: Members recall that, as of 2012, the Agency was given the task of managing and carrying out technical, scientific and administrative aspects of Regulation (EU) No 528/2012 of the European Parliament and of the Council (Biocidal Products Regulation - BPR), as well as similar tasks related to the export and import of hazardous chemicals. They also recall that, with respect to the BPR Regulation, the Agency's activities are financed partially through fees paid by industry and partially through a Union subsidy. Ensuring transparency is thus of the utmost importance. They also acknowledge with concern that the Agency had to carry out its biocide activities under severe budgetary and human resources restrictions in 2014 , because the biocide fees collected in 2014 were much lower (EUR 1.3 million) than estimated, and covered only 17% of biocide-related expenditure. As a result, the Agency's budgetary line was reinforced through budgetary transfer by the Commission. They also note the difficulties of the Agency to obtain additional subsidy in those years where the financial revenue from biocide fees will be lower than estimated which will make it extremely difficult for the Agency to continue to deliver on all its non-fee related obligations. They recall that, in accordance with the REACH Regulation, the Agency is financed through fees paid by industry for the registration of chemical substances, and that in 2014, the Agency was fully financed through fee income for its REACH and classification, labelling and packaging (CLP) operations.
Members also made a series of observations regarding commitments and carryovers, payments, contract award, recruitment and internal audit and control procedures.
As far as the issue of preventing conflicts of interest is concerned, Members note the Agency has four scientific committees set up by its founding regulation which issue formal opinions and recommendations. Those committees consist of experts, almost all of whom are public officials, nominated or appointed by the Member States, while the stakeholders are only allowed to participate as observers. They acknowledge that the prevention of conflicts of interest for those committee members is strictly managed by the Agency’s procedure on the prevention and management of potential conflicts of interest, including annual declarations of interests and oral declarations at the start of each meeting.
Having examined the revenue and expenditure accounts for the financial year 2014 and the balance sheet as at 31 December 2014 of the European Chemicals Agency (ECHA), as well as the Court of Auditors' report on the annual accounts of the Agency for the financial year 2014, accompanied by the Agency's replies to the Court's observations, the Council recommended the European Parliament to give a discharge to the Executive Director of the Agency in respect of the implementation of the budget for the financial year 2014.
The Council welcomed the Court's opinion that, in all material respects, the Agency's annual accounts present fairly its financial position as at 31 December 2014 and the results of its operations and its cash flows for the year then ended, in accordance with the provisions of the Agency's Financial Regulation, and that the underlying transactions for 2014 are legal and regular in all material respects.
Nevertheless, the Council has made some observations which may be summarised as follows:
financial programming : the Council reiterated its call on the Agency to continue improving its financial management in order to limit carry-overs of committed appropriations to the following financial year to the strict minimum, in line with the budgetary principle of annuality. It invites the Agency to exercise budgetary prudence when forecasting expected revenues from fees.
PURPOSE: presentation of the EU Court of Auditors’ report on the annual accounts of the European Chemicals Agency (ECHA) for the financial year 2014, together with the Agency’s reply.
CONTENT: in accordance with the tasks conferred on the Court of Auditors by the Treaty on the Functioning of the European Union, the Court presents to the European Parliament and to the Council, in the context of the discharge procedure, a Statement of Assurance as to the reliability of the annual accounts of each institution, body or agency of the EU, and the legality and regularity of the transactions underlying them, on the basis of an independent external audit.
This audit concerned, amongst others, the annual accounts of the European Chemicals Agency.
Statement of Assurance : pursuant to the provisions of Article 287 of the Treaty on the Functioning of the European Union (TFEU), the Court has audited:
the annual accounts of the Agency, which comprise the financial statements and the reports on the implementation of the budget for the financial year ended 31 December 2014; the legality and regularity of the transactions underlying those accounts.
Opinion on the reliability of the accounts : in the Court’s opinion, the Agency’s annual accounts present fairly, in all material respects, its financial position as at 31 December 2014 and the results of its operations and its cash flows for the year then ended, in accordance with the provisions of its Financial Regulation and the accounting rules adopted by the Commission’s accounting officer.
Opinion on the legality and regularity of the transactions underlying the accounts : the Court considers that the transactions underlying the annual accounts for the year ended 31 December 2014 are legal and regular in all material respects.
The report also makes a series of observations on the budgetary and financial management of the Agency, accompanied by the latter’s response. The main observations may be summarised as follows:
The Court’s observations:
budgetary management : the court indicates that the level of committed appropriations carried over to 2014 for operational expenses was EUR 8.5 million, i.e. 35 %. These carry-overs mainly resulted from the multiannual nature of planned IT development projects (EUR 4.5 million), and costs for translations ordered in 2014 but not received and paid by the end of the year. The expenditure for procedures associated with one new specific activity of the Agency, the implementation of the Regulation concerning biocidal products was to be, covered by application fees for the registration of these products. However, fees collected in 2014 covered only 17 % of this expenditure.
The Agency’s reply :
budgetary management : the Agency appreciates the conclusion of the Court and will continue to be attentive to avoid any non-justified carry-over operations. It states that the fees triggered by the 2014 applications under the Biocidal Products Regulation covered the Agency’s related cost only for a small part. The original Commission assumption, that the Agency would be largely self-financing, has proven to be incorrect, as the national and EU fees have a bias in favour of national applications and mutual recognitions rather than Union authorisations for biocidal products.
Lastly, the Court of Auditors’ report contains a summary of the Agency’s activities in 2014. This is focused on the following:
Budget : EUR 113.2 million, of which:
revenue from fees: EUR 27.2 million; EUR 25.9 million in respect of fees and charges under the REACH Regulation and EUR 1.3 million in respect of fees and charges collected under the Biocidal Products Regulation; Union contribution: EUR 7.8 million, including support for the implementation of the Regulation concerning the making available on the market and use of biocidal products, the balancing contribution, an EFTA contribution and a contribution under the Regulation concerning the export and import of hazardous chemicals.
Activities:
number of registration dossiers processed: 9 001; number of confidentiality requests assessments completed: 636; number of new inquiries received: 1 000; number of decisions issued on data sharing disputes: 5; number of substances on which info made public (excluding confidential info): 12 888.
The Agency also:
evaluated conformity checks; evaluated final decisions on testing proposals; received 6.4 million classification and labelling notifications for over 1 33 000 substances; gave advice and assistance, including to EU institutions and bodies; established of scientific IT tools; conducted communication activities (including through its website or specific publications); carried out international cooperation in its area of competence; achieved SO 9001 certification; successfully concluded open calls for tenders.
Lastly, 2 094 biocides applications (applications for new active substances, renewals or review, Union authorisations of products) were processed and transmitted to Member States.
PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2014, as part of the 2014 discharge procedure.
Analysis of the accounts of the European Chemicals Agency (ECHA) .
CONTENT: this Commission document sets out the consolidated annual accounts of the European Union for the financial year 2014 as prepared on the basis of the information presented by the institutions, organisations and bodies of the EU, in accordance with Article 148 (2) of the Financial Regulation applicable to the EU's General Budget, including the European Chemicals Agency (ECHA).
The document contains the figures on which the discharge procedure is based.
On this basis, the Financial Controller of the European Commission ensures the certification of the consolidated accounts as declared by the institutions, agencies and bodies of the European Union.
Discharge procedure of the EU agencies : the EU Budget finances a wide range of policies and programmes throughout the EU. In accordance with the priorities set by the European Parliament and the Council in the multi-annual financial framework (MFF), the European Commission carries out specific programmes, activities and projects in the field with the technical support of some specialised agencies.
The consolidated annual accounts of the EU provide information on the activities of the institutions, agencies and other bodies of the EU from a budgetary and accrual accounting perspective.
The consolidated reports on the implementation of the general budget of the EU include the budget implementation of all Institutions. Agencies do not have a separate budget inside the EU budget ; and they are partially financed by a Commission budget subsidy.
This document sets out how the Agencies spent and implemented their budget in 2014. Each agency is subject to its own discharge procedure.
ECHA : in 2014, the tasks and budget of this agency were as follows:
description of ECHA's tasks : ECHA, located in Helsinki (FI), was set up by Regulation (EC) No 1907/2006 of the European Parliament and of the Council to help businesses comply with the legislation in force, promote the safe use of chemicals, provide information on chemicals and assess hazardous substances; ECHA's budget for the 2014 financial year : the Agency’s budget for 2014, as presented in the Commission document on the consolidated annual accounts of the European Union, gives the following figures:
Commitment appropriations :
- committed : EUR 115 million;
- paid : EUR 111 million;
- carried-over : 0.
Payment appropriations :
- committed : EUR 127 million;
- paid : EUR 112 million;
- carried-over : EUR 11 million.
Please refer also to the final accounts of the ECHA .
PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2014, as part of the 2014 discharge procedure.
Analysis of the accounts of the European Chemicals Agency (ECHA) .
CONTENT: this Commission document sets out the consolidated annual accounts of the European Union for the financial year 2014 as prepared on the basis of the information presented by the institutions, organisations and bodies of the EU, in accordance with Article 148 (2) of the Financial Regulation applicable to the EU's General Budget, including the European Chemicals Agency (ECHA).
The document contains the figures on which the discharge procedure is based.
On this basis, the Financial Controller of the European Commission ensures the certification of the consolidated accounts as declared by the institutions, agencies and bodies of the European Union.
Discharge procedure of the EU agencies : the EU Budget finances a wide range of policies and programmes throughout the EU. In accordance with the priorities set by the European Parliament and the Council in the multi-annual financial framework (MFF), the European Commission carries out specific programmes, activities and projects in the field with the technical support of some specialised agencies.
The consolidated annual accounts of the EU provide information on the activities of the institutions, agencies and other bodies of the EU from a budgetary and accrual accounting perspective.
The consolidated reports on the implementation of the general budget of the EU include the budget implementation of all Institutions. Agencies do not have a separate budget inside the EU budget ; and they are partially financed by a Commission budget subsidy.
This document sets out how the Agencies spent and implemented their budget in 2014. Each agency is subject to its own discharge procedure.
ECHA : in 2014, the tasks and budget of this agency were as follows:
description of ECHA's tasks : ECHA, located in Helsinki (FI), was set up by Regulation (EC) No 1907/2006 of the European Parliament and of the Council to help businesses comply with the legislation in force, promote the safe use of chemicals, provide information on chemicals and assess hazardous substances; ECHA's budget for the 2014 financial year : the Agency’s budget for 2014, as presented in the Commission document on the consolidated annual accounts of the European Union, gives the following figures:
Commitment appropriations :
- committed : EUR 115 million;
- paid : EUR 111 million;
- carried-over : 0.
Payment appropriations :
- committed : EUR 127 million;
- paid : EUR 112 million;
- carried-over : EUR 11 million.
Please refer also to the final accounts of the ECHA .
Documents
- Results of vote in Parliament: Results of vote in Parliament
- Decision by Parliament: T8-0169/2016
- Debate in Parliament: Debate in Parliament
- Committee report tabled for plenary: A8-0118/2016
- Amendments tabled in committee: PE576.928
- Committee draft report: PE569.747
- Supplementary non-legislative basic document: 05584/2016
- Committee opinion: PE571.775
- Court of Auditors: opinion, report: OJ C 409 09.12.2015, p. 0131
- Court of Auditors: opinion, report: N8-0130/2015
- Non-legislative basic document: COM(2015)0377
- Non-legislative basic document: EUR-Lex
- Non-legislative basic document published: COM(2015)0377
- Non-legislative basic document published: EUR-Lex
- Non-legislative basic document: COM(2015)0377 EUR-Lex
- Court of Auditors: opinion, report: OJ C 409 09.12.2015, p. 0131 N8-0130/2015
- Committee opinion: PE571.775
- Supplementary non-legislative basic document: 05584/2016
- Committee draft report: PE569.747
- Amendments tabled in committee: PE576.928
Activities
- Marina ALBIOL GUZMÁN
Plenary Speeches (1)
- Jean ARTHUIS
Plenary Speeches (1)
- Marie-Christine ARNAUTU
Plenary Speeches (1)
- Jonathan ARNOTT
Plenary Speeches (1)
- Zoltán BALCZÓ
Plenary Speeches (1)
- Zigmantas BALČYTIS
Plenary Speeches (1)
- Hugues BAYET
Plenary Speeches (1)
- Xabier BENITO ZILUAGA
Plenary Speeches (1)
- José BLANCO LÓPEZ
Plenary Speeches (1)
- Marie-Christine BOUTONNET
Plenary Speeches (1)
- Renata BRIANO
Plenary Speeches (1)
- Steeve BRIOIS
Plenary Speeches (1)
- Gianluca BUONANNO
Plenary Speeches (1)
- James CARVER
Plenary Speeches (1)
- Nicola CAPUTO
Plenary Speeches (1)
- Alberto CIRIO
Plenary Speeches (1)
- Therese COMODINI CACHIA
Plenary Speeches (1)
- Daniel DALTON
Plenary Speeches (1)
- Michel DANTIN
Plenary Speeches (1)
- William (The Earl of) DARTMOUTH
Plenary Speeches (1)
- Mireille D'ORNANO
Plenary Speeches (1)
- Norbert ERDŐS
Plenary Speeches (1)
- Edouard FERRAND
Plenary Speeches (1)
- Doru-Claudian FRUNZULICĂ
Plenary Speeches (1)
- Ildikó GÁLL-PELCZ
Plenary Speeches (1)
- Elisabetta GARDINI
Plenary Speeches (1)
- Arne GERICKE
Plenary Speeches (1)
- Sylvie GODDYN
Plenary Speeches (1)
- Tania GONZÁLEZ PEÑAS
Plenary Speeches (1)
- Takis HADJIGEORGIOU
Plenary Speeches (1)
- Brian HAYES
Plenary Speeches (1)
- Marian HARKIN
Plenary Speeches (1)
- Cătălin Sorin IVAN
Plenary Speeches (1)
- Diane JAMES
Plenary Speeches (1)
- Ivan JAKOVČIĆ
Plenary Speeches (1)
- Philippe JUVIN
Plenary Speeches (1)
- Barbara KAPPEL
Plenary Speeches (1)
- Afzal KHAN
Plenary Speeches (1)
- Bernd KÖLMEL
Plenary Speeches (1)
- Giovanni LA VIA
Plenary Speeches (1)
- Marine LE PEN
Plenary Speeches (1)
- Bernd LUCKE
Plenary Speeches (1)
- Ivana MALETIĆ
Plenary Speeches (1)
- Andrejs MAMIKINS
Plenary Speeches (1)
- Dominique MARTIN
Plenary Speeches (1)
- Notis MARIAS
Plenary Speeches (1)
- Jean-Luc MÉLENCHON
Plenary Speeches (1)
- Marlene MIZZI
Plenary Speeches (1)
- Sophie MONTEL
Plenary Speeches (1)
- Renaud MUSELIER
Plenary Speeches (1)
- Liadh NÍ RIADA
Plenary Speeches (1)
- Franz OBERMAYR
Plenary Speeches (1)
- Florian PHILIPPOT
Plenary Speeches (1)
- Marijana PETIR
Plenary Speeches (1)
- Franck PROUST
Plenary Speeches (1)
- Julia REID
Plenary Speeches (1)
- Claude ROLIN
Plenary Speeches (1)
- Lola SÁNCHEZ CALDENTEY
Plenary Speeches (1)
- Maria Lidia SENRA RODRÍGUEZ
Plenary Speeches (1)
- Siôn SIMON
Plenary Speeches (1)
- Monika SMOLKOVÁ
Plenary Speeches (1)
- Davor ŠKRLEC
Plenary Speeches (1)
- Igor ŠOLTES
Plenary Speeches (1)
- Joachim STARBATTY
Plenary Speeches (1)
- Beatrix von STORCH
Plenary Speeches (1)
- Patricija ŠULIN
Plenary Speeches (1)
- Tibor SZANYI
Plenary Speeches (1)
- Dubravka ŠUICA
Plenary Speeches (1)
- Pavel TELIČKA
Plenary Speeches (1)
- Miguel VIEGAS
Plenary Speeches (1)
Votes
A8-0118/2016 - Derek Vaughan - Résolution #
Amendments | Dossier |
22 |
2015/2184(DEC)
2015/12/22
ENVI
8 amendments...
Amendment 1 #
Draft opinion Paragraph 3 3. Recalls that, with respect to the BPR Regulation, the Agency's biocidal products are financed partially through fees paid by industry and partially through an EU subsidy, as referred to in Article 185 of the Financial Regulation; highlights therefore that ensuring transparency is of the utmost importance;
Amendment 2 #
Draft opinion Paragraph 10 a (new) 10a. Recalls that the Parliament raised serious concerns with regard to the work of Agency´s committees in 2014 in its resolution of 25 November 2015 on draft Commission Implementing Decision XXX granting an authorisation for uses of bis(2-ethylhexhyl) phthalate (DEHP) under Regulation (EC) No 1907/2006 of the European Parliament and of the Council1a, and expects a clear response from the Agency to the issues raised therein; __________________ 1a P8_TA(2015)0409.
Amendment 3 #
Draft opinion Paragraph 10 b (new) 10b. Notes furthermore with concern that in the case referred to in its resolution of 25 November 2015 on draft Commission Implementing Decision XXX granting an authorisation for uses of bis(2- ethylhexhyl) phthalate (DEHP) the Agency´s committees: - accepted deficient applications, - took the initiative to do the work of the applicants and tried to justify an authorisation under a route that the applicants did not even apply for, - used simplistic arguments that are not within their remit to justify the authorisation of substances of very high concern, and - accepted unsubstantiated economic arguments to justify the acceptance of serious health risks;
Amendment 4 #
Draft opinion Paragraph 11 11. Welcomes the transparency approach adopted by the Agency's Management Board, hereby also responding to the European Ombudsman’s request; calls on the Agency constantly to update its internal procedures in order to ensure the independence of its staff;
Amendment 5 #
Draft opinion Paragraph 11 a (new) 11a. Notes that the Agency is continuously improving the dissemination of data to the European citizens and the public at large, inter alia by including the exposure scenarios and user friendly structured substance profiles to the dissemination portal; encourages the Agency to step up its efforts in order to allow all stakeholders to act on the basis of accurate data by disseminating all information held by the Agency on substances whether on their own, in preparations or in articles as listed in Article 119 of REACH Regulation, including the tonnage band within which a particular substance has been registered;
Amendment 6 #
Draft opinion Paragraph 11 a (new) 11a. Asks the responsible body of the Agency to implement the anti-fraud strategy as soon as possible;
Amendment 7 #
Draft opinion Paragraph 13 a (new) 13a. Notes the reservation to the 2013 declaration of assurance awarded by the Court of Auditors, given that the mandate of the Agency does not include controls or inspections at national level and therefore cannot confirm that only registered or authorised substances and products, for which a fee has been paid to the Agency, are available on the European market;
Amendment 8 #
Draft opinion Paragraph 15 15. Recommends, based on the facts available, that
source: 573.122
2016/03/04
CONT
14 amendments...
Amendment 1 #
Proposal for a decision 1 Paragraph 1 1.
Amendment 10 #
Motion for a resolution Paragraph 16 e (new) 16e. Stresses in the context of 'proportionality', i.e.whether or not the socio-economic benefits of an authorisation outweigh the risk to human health or the environment, that this task falls solely on the Commission as the risk manager pursuant to Article 60(4) of REACH, and not on SEAC, whose task pursuant to Article 64(4b) of REACH is to merely assess the socio-economic factors;
Amendment 11 #
Motion for a resolution Paragraph 16 f (new) 16f. Notes with great concern that the issues raised by the European Parliament are not an isolated case, as documented by the report "A roadmap to revitalise REACH" by the European Environment Bureau1a; _________________ 1ahttp://www.eeb.org/index.cfm/library/a- roadmap-to-revitalise-reach/
Amendment 12 #
Motion for a resolution Paragraph 16 g (new) 16g. Calls on the Executive Director of ECHA to ensure that a) the committees take the initiative to revise their procedures to align them with the letter and the spirit of REACH to ensure inter alia that such deficient applications do not receive a positive opinion, that the committees do not assess applications under conditions that were not applied for by the applicants, and that they stay within their mandate, in particular by SEAC no longer concluding on the proportionality of an authorisation, b) the committees do not accept unsubstantiated arguments to justify authorisation, c) to prepare a draft opinion of the Management Board concerning the revision of the procedures of the committees, d) SEAC revises its opinion on DEHP accordingly;
Amendment 13 #
Motion for a resolution Paragraph 16 h (new) 16h. Calls also on the Executive Director of ECHA to respond in a comprehensive manner to the recommendations by the European Environment Bureauin its report, and to take corrective action where necessary;
Amendment 14 #
Motion for a resolution Paragraph 16 i (new) 16i. States that the annual reports of the EU institutions and agencies could play an important role in compliance regarding transparency, accountability and integrity; calls for the EU institutions and agencies to include a standard chapter on these components in their annual reports;
Amendment 2 #
Proposal for a decision 1 Paragraph 1 1.
Amendment 3 #
Proposal for a decision 2 Paragraph 2 2.
Amendment 4 #
Proposal for a decision 2 Paragraph 2 2.
Amendment 5 #
Motion for a resolution Paragraph 3 3. Notes that the expenditure for procedures associated with the new implementation of the Regulation (EU) No 528/2012 of the European Parliament and of the Council (BPR Regulation)13 was to be covered by application fees for the registration of biocidal products; acknowledges that the fees collected in 2014 covered only 17 % of this expenditure and the remaining part was financed by contributions to the Agency’s budget from the Union and the European Free Trade Association (EFTA) countries; takes note of the Agency's comment about the Commission's incorrect assumption of the Agency's largely self-financing nature regarding the BPR related costs; __________________ 13 Regulation (EU) No 528/2012 of the European Parliament and of the Council of
Amendment 6 #
Motion for a resolution Paragraph 16 a (new) 16a. Recalls that the European Parliament raised serious concerns with regard to the work of ECHA committees in 2014 in its resolution of 25 November 2015 on draft Commission Implementing Decision XXX granting an authorisation for uses of bis(2-ethylhexhyl) phthalate (DEHP) under Regulation (EC) No 1907/2006 of the European Parliament and of the Council 1a, where it objected by a very large majority to that draft decision, in particular that: - granting an authorisation for a substance of very high concern based on an application that is fraught with so many deficiencies would set a very bad precedent for future authorisation decisions under REACH, - its committee for Socio-Economic Analysis (SEAC) went beyond its mandate by providing a conclusion on the proportionality of an authorisation, - SEAC used simplistic political arguments that are not within its remit and against existing legal provisions to justify the authorisation; __________________ 1aP8_TA(2015)0409.
Amendment 7 #
Motion for a resolution Paragraph 16 b (new) 16b. Notes furthermore with concern that SEAC assessed whether the application could be granted under conditions that the applicant did not even apply for, and furthermore accepted unsubstantiated arguments to justify the acceptance of serious health risks;
Amendment 8 #
Motion for a resolution Paragraph 16 c (new) 16c. Welcomes the initiative of ECHA to meet with staff of all political groups in the European Parliament on 26 February 2016 to respond to the concerns raised in its resolution of 25 November 2015 on draft Commission Implementing Decision XXX granting an authorisation for uses of bis(2-ethylhexhyl) phthalate (DEHP) under Regulation (EC) No 1907/2006 of the European Parliament and of the Council, and that ECHA high-level staff acknowledged at that meeting that ECHA and its committees should not take views on policy matters and that the statement on recycling in their opinion was inconsistent with SEAC's technical- scientific role;
Amendment 9 #
Motion for a resolution Paragraph 16 d (new) 16d. Notes however with great concern that ECHA continues to stand by the conclusions of the committees in favour of authorisation of DEHP despite the serious deficiencies across all aspects of the application and the assessment of the application under conditions that the applicant had not applied for; continues to consider that such an approach violates inter alia the principle laid down in Article 1(3) of REACH that it is up to manufacturers to prove the safety of chemicals, a principle which is especially relevant in the case of the authorisation of substances of very high concern, where the burden of proof is clearly on the applicant;
source: 576.928
|
History
(these mark the time of scraping, not the official date of the change)
committees/0/shadows/1/name |
Old
VISTISEN Anders PrimdahlNew
VISTISEN Anders |
docs/0 |
|
events/0/date |
Old
2015-07-23T00:00:00New
2015-07-22T00:00:00 |
committees/0/shadows/3 |
|
docs/1/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE571.775&secondRef=02New
https://www.europarl.europa.eu/doceo/document/ENVI-AD-571775_EN.html |
docs/3/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE569.747New
https://www.europarl.europa.eu/doceo/document/CONT-PR-569747_EN.html |
docs/4/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE576.928New
https://www.europarl.europa.eu/doceo/document/CONT-AM-576928_EN.html |
events/1/type |
Old
Committee referral announced in Parliament, 1st reading/single readingNew
Committee referral announced in Parliament |
events/2/type |
Old
Vote in committee, 1st reading/single readingNew
Vote in committee |
events/3 |
|
events/3 |
|
events/4/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20160427&type=CRENew
https://www.europarl.europa.eu/doceo/document/CRE-8-2015-04-27-TOC_EN.html |
events/6 |
|
events/6 |
|
committees/0 |
|
committees/0 |
|
committees/1 |
|
committees/1 |
|
events/3/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2016-0118&language=ENNew
http://www.europarl.europa.eu/doceo/document/A-8-2016-0118_EN.html |
events/6/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2016-0169New
http://www.europarl.europa.eu/doceo/document/TA-8-2016-0169_EN.html |
committees/0 |
|
committees/0 |
|
commission |
|
committees |
|
docs |
|
events |
|
procedure |
|